Open company graph database — free web & API
Login

Eisai (Liaoning) Pharmaceutical Co., Ltd.

Eisai(遼寧)製薬株式会社Alias
Ticker
—
Listed market
—
Country
China
Employees (non-consolidated)
—
Related companies
11
§01

Basic information

BASIC
Head office
Chief executive
Employees (non-consolidated)
Employees (consolidated)
Start date
End date
§02

Websites

1 DOMAINS
§03

Business

27
Pharmaceutical salesDrug distributionOverseas salesBusiness ActivitiesProductsProduction and Logistics (Demand Chain Systems)Corporate Venture CapitalPharmaceutical business製造・物流Product salesDrug developmentOncology drug development and commercializationSleep disorder drug development and commercializationAnti-epileptic drug development and commercializationPharmaceutical DevelopmentDrug ManufacturingDrug DistributionQuality AssuranceSupply Chain ManagementBiologics StrategyStrategic PlanningCost ManagementTalent ManagementPharmaceutical product manufacturingGlobal distribution of medicinesDemand chain system developmentEnsuring stable supply of high-quality medicines during emergencies
§04

Related companies

11 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Eisai Australia Pty. Ltd.
Group
Eisai Korea Inc.
Group
Eisai New Zealand Ltd.
Group
Eisai Pharmaceuticals Africa (Pty) Ltd
Group
Eisai Vietnam Co., Ltd.
Group
Eisai Co., Ltd.
Group
Eisai (Malaysia) Sdn. Bhd.
Group
SampleNet Corporation
Group
EA Pharma Co., Ltd.
Group
HI-Eisai Pharmaceutical, Inc.
Group
Eisai Pharmaceuticals India Pvt. Ltd.
Group
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

2 EVENTS

Shenyang Eisai Pharmaceutical Co., Ltd. is established as a Chinese–foreign contractual joint venture in pharmaceutical manufacturing and sales in Shenyang, China.Sources

Eisai completes acquisition of Chinese generic pharmaceutical company Liaoning Tianyi Biological Pharmaceutical Co., Ltd. (new trading name: Eisai (Liaoning) Pharmaceutical Co., Ltd.)Sources

§07

News

0 ARTICLES

There is no news.

§09

Sources & updates

SOURCES
↑